NSIS-B:CPH
Novozymes A/S
DKK ४५४.८०
arrow_downward
-०.७०%(-३.२०) 1D
अक्टोबर १६, १७:००:०० GMT+२ · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKK ४५२.८०
High
DKK ४५६.८०
Low
DKK ४५२.००
Mkt. cap
१.८३ खरब
Avg. vol.
६.०५ लाख
Volume
९.५४ लाख
52-wk high
DKK ४६५.००
52-wk low
DKK ३३६.८०
Shares outstanding
४१.४६ करोड
No. of employees
११ हजार
Open
DKK ४५२.८०
High
DKK ४५६.८०
Low
DKK ४५२.००
Mkt. cap
१.८३ खरब
Avg. vol.
६.०५ लाख
Volume
९.५४ लाख
52-wk high
DKK ४६५.००
52-wk low
DKK ३३६.८०
Shares outstanding
४१.४६ करोड
No. of employees
११ हजार
News stories
From web sources and news partners
Law360
·
२७ मिनेट पहिले
Nasdaq Sued Over Delisting Of Social Media Co.
Simply Wall Street
·
१९ मिनेट पहिले
SK Hynix (NasdaqGS:SKHY) Stock Trades At A Discount After A 22% Fall
Seeking Alpha
·
२७ मिनेट पहिले
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
MarketWatch
·
४ घण्टा पहिले
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Novonesis is a Danish biotechnology company. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has approximately 11,600 employees and activities in over 45 countries. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees११.१ हजार
Founded२०००
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com